tiprankstipranks
Trending News
More News >
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market

AFT Pharmaceuticals Ltd. (AFP) Ratios

Compare
5 Followers

AFT Pharmaceuticals Ltd. Ratios

AU:AFP's free cash flow for Q2 2025 was $0.42. For the 2025 fiscal year, AU:AFP's free cash flow was decreased by $ and operating cash flow was $-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
2.30 2.38 2.67 2.12 2.20
Quick Ratio
1.23 1.31 1.52 1.07 1.30
Cash Ratio
0.26 0.12 0.27 0.10 0.24
Solvency Ratio
0.23 0.17 0.32 0.13 0.19
Operating Cash Flow Ratio
0.63 0.29 0.49 0.02 0.59
Short-Term Operating Cash Flow Coverage
0.00 4.73 3.54 0.15 7.44
Net Current Asset Value
$ 28.27M$ 19.80M$ 12.53M$ -642.00K$ -14.46M
Leverage Ratios
Debt-to-Assets Ratio
0.19 0.26 0.32 0.40 0.54
Debt-to-Equity Ratio
0.37 0.52 0.65 1.15 2.74
Debt-to-Capital Ratio
0.27 0.34 0.39 0.54 0.73
Long-Term Debt-to-Capital Ratio
0.24 0.31 0.35 0.48 0.70
Financial Leverage Ratio
1.88 2.02 2.04 2.87 5.05
Debt Service Coverage Ratio
5.78 2.86 3.26 1.43 1.15
Interest Coverage Ratio
5.51 6.85 8.37 3.11 1.43
Debt to Market Cap
0.09 0.10 0.10 0.08 0.10
Interest Debt Per Share
0.34 0.39 0.41 0.44 0.53
Net Debt to EBITDA
0.73 1.63 1.47 3.14 3.49
Profitability Margins
Gross Profit Margin
44.78%46.59%47.40%43.09%45.71%
EBIT Margin
13.25%11.92%16.21%10.02%19.82%
EBITDA Margin
14.29%13.02%17.01%10.99%11.14%
Operating Profit Margin
10.47%12.56%15.65%9.47%10.89%
Pretax Profit Margin
11.35%10.09%14.34%6.97%12.19%
Net Profit Margin
8.04%6.80%15.23%6.88%12.02%
Continuous Operations Profit Margin
8.04%6.80%15.23%6.88%12.02%
Net Income Per EBT
70.89%67.43%106.22%98.67%98.56%
EBT Per EBIT
108.38%80.32%91.64%73.66%111.95%
Return on Assets (ROA)
9.45%7.20%15.59%7.40%14.58%
Return on Equity (ROE)
17.78%14.54%31.85%21.27%73.56%
Return on Capital Employed (ROCE)
17.05%18.16%20.75%14.66%18.57%
Return on Invested Capital (ROIC)
12.00%17.14%26.42%17.33%21.71%
Return on Tangible Assets
10.49%8.08%17.83%8.69%17.73%
Earnings Yield
4.95%2.97%5.28%1.55%2.95%
Efficiency Ratios
Receivables Turnover
4.73 3.95 4.36 3.87 4.67
Payables Turnover
4.23 3.77 5.68 4.38 6.65
Inventory Turnover
2.18 1.97 2.05 1.91 2.52
Fixed Asset Turnover
50.78 46.55 38.78 29.87 26.22
Asset Turnover
1.17 1.06 1.02 1.08 1.21
Working Capital Turnover Ratio
3.39 3.03 3.09 3.43 9.19
Cash Conversion Cycle
157.97 180.50 197.79 201.79 168.05
Days of Sales Outstanding
77.14 92.32 83.65 94.32 78.21
Days of Inventory Outstanding
167.13 184.98 178.40 190.85 144.73
Days of Payables Outstanding
86.29 96.79 64.27 83.38 54.89
Operating Cycle
244.26 277.29 262.05 285.17 222.95
Cash Flow Ratios
Operating Cash Flow Per Share
0.28 0.11 0.13 <0.01 0.14
Free Cash Flow Per Share
0.18 0.11 0.13 <0.01 0.14
CapEx Per Share
0.09 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.67 0.98 0.98 0.88 0.99
Dividend Paid and CapEx Coverage Ratio
2.70 59.03 43.02 2.67 22.61
Capital Expenditure Coverage Ratio
3.03 59.03 43.02 8.06 161.72
Operating Cash Flow Coverage Ratio
0.90 0.31 0.35 0.02 0.32
Operating Cash Flow to Sales Ratio
0.15 0.07 0.11 <0.01 0.14
Free Cash Flow Yield
6.13%3.19%3.68%0.13%3.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.20 33.64 18.93 64.45 33.91
Price-to-Sales (P/S) Ratio
1.62 2.29 2.88 4.43 4.08
Price-to-Book (P/B) Ratio
3.59 4.89 6.03 13.71 24.94
Price-to-Free Cash Flow (P/FCF) Ratio
16.31 31.35 27.18 763.41 29.11
Price-to-Operating Cash Flow Ratio
10.92 30.82 26.54 668.75 28.93
Price-to-Earnings Growth (PEG) Ratio
0.40 -0.71 0.12 -1.66 -0.07
Price-to-Fair Value
3.59 4.89 6.03 13.71 24.94
Enterprise Value Multiple
12.10 19.21 18.42 43.48 40.07
Enterprise Value
335.40M 391.74M 408.23M 540.57M 471.49M
EV to EBITDA
12.10 19.21 18.42 43.48 40.07
EV to Sales
1.73 2.50 3.13 4.78 4.46
EV to Free Cash Flow
17.35 34.27 29.53 822.78 31.89
EV to Operating Cash Flow
11.62 33.69 28.85 720.76 31.69
Tangible Book Value Per Share
0.68 0.54 0.44 0.20 0.02
Shareholders’ Equity Per Share
0.84 0.70 0.59 0.35 0.16
Tax and Other Ratios
Effective Tax Rate
0.29 0.33 0.06 0.01 0.01
Revenue Per Share
1.85 1.49 1.24 1.08 1.01
Net Income Per Share
0.15 0.10 0.19 0.07 0.12
Tax Burden
0.71 0.67 1.06 0.99 0.99
Interest Burden
0.86 0.85 0.88 0.70 0.62
Research & Development to Revenue
0.04 0.04 0.04 0.03 0.02
SG&A to Revenue
0.06 0.07 0.06 0.07 0.09
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
1.85 1.09 0.71 0.10 1.17
Currency in NZD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis